CoChat

Glucose-induced phosphorylation of the insulin receptor. Functional effects and characterization of phosphorylation sites.

Open access
Pillay, T S, Xiao, S, Olefsky, J M · 1996 · Journal of Clinical Investigation
Cited by 75

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Elevated glucose concentrations have been reported to inhibit insulin receptor kinase activity. We studied the effects of high glucose on insulin action inRat1 fibroblasts transfected with wild-type human insulin receptor (HIRcB) and a truncated receptor lacking the COOH-terminal 43 amino acids ( ⌬ CT).In both cell lines, 25 mM glucose impaired receptor and insulin receptor substrate-1 phosphorylation by 34%, but IGF-1 receptor phosphorylation was unaffected.Phosphatidylinositol 3-kinase activity and bromodeoxyuridine uptake were decreased by 85 and 35%, respectively.This was reversed by coincubation with a protein kinase C (PKC) inhibitor or microinjection of a PKC inhibitor peptide.Phosphopeptide mapping revealed that high glucose or PMA led to serine/threonine phosphorylation of similar peptides.Inhibition of the microtubule-associated protein (MAP) kinase cascade by the MAP kinase kinase inhibitor PD98059 did not reverse the impaired phosphorylation.We conclude that high glucose inhibits insulin action by inducing serine phosphorylation through a PKC-mediated mechanism at the level of the receptor at sites proximal to the COOH-terminal 43 amino acids.This effect is independent of activation of the MAP kinase cascade.Proportionately, the impairment of insulin receptor substrate-1 tyrosine phosphorylation is greater than that of the insulin receptor resulting in attenuated phosphatidylinositol 3-kinase activation and mitogenic signaling.( J. Clin.Invest.1996.97: 613-620.)Key words: insulin receptor • insulin resistance • hyperglycemia • protein kinase C • phosphorylation MethodsCell culture and materials.The cell lines used were Rat1 fibroblasts stably transfected with and overexpressing both wild-type human insulin receptor (HIRcB) and mutant receptors lacking the distal 43 amino acids of the ␤ subunit (19-21).These were cultured as described previously in DME/F12 containing 500 nM methotrexate.Porcine insulin was purchased from Eli Lilly & Co. (Indianapolis, IN).Enhanced chemiluminescence detection reagents were obtained from Amersham Corp. (Arlington Heights, IL).Nitrocellulose was provided by Schleicher & Schuell, Inc. (Keene, NH).Immunoblotting.Cells were routinely cultured in 35-mm 6-well dishes as described ( 22) and used at subconfluence.Approximately 16-24 h before experimental manipulations, the serum-containing media were removed and replaced with fresh serum-free DME (Sigma Immunochemicals, St. Louis, MO) containing 1 mM glucose for 16 h.The appropriate amounts of glucose were then added for the This work was presented in part at the Western section of the American Federation for Clinical Research Meeting on 9 February 1995 in Carmel, CA.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci118457

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 75

Metadata

Authors
Pillay, T. S., Xiao, S., & Olefsky, J. M.
Venue
Journal of Clinical Investigation
Published
1996-02-01
Volume
97
Issue
3
Pages
613-620
ISSN
0021-9738 (ISSN-L)
OpenAlex
W1995787968
Cited by
75
References
1
FWCI
2.60
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Glucose-induced phosphorylation of the insulin receptor. Functional effects and characterization of phosphorylation sites. https://app.cochat.ai/papers/10.1172/jci118457
The paper
Pillay, T. S., Xiao, S., & Olefsky, J. M. (1996). Glucose-induced phosphorylation of the insulin receptor. Functional effects and characterization of phosphorylation sites. Journal of Clinical Investigation. https://doi.org/10.1172/jci118457

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.